Last edition
News about "Machine Learning"
Revvity Launches AI Platform for Molecular and Materials Discovery
Revvity has launched a new AI-powered Models-as-a-Service (MaaS) platform designed to integrate in-silico molecular and materials design with experimental data, enabling continuous learning, improved predictive accuracy, and faster scientific discovery.
Machine Learning | 17/12/2025 | By News Bureau
Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals with Pfizer
Adaptive Biotechnologies has signed two immune receptor licensing agreements with Pfizer, covering a T-Cell Receptor (TCR) discovery collaboration in rheumatoid arthritis and access to Adaptive’s proprietary TCR-antigen datasets for immunology R&D.
Machine Learning | 16/12/2025 | By News Bureau
Xcell Biosciences and Culture Biosciences Partner to Improve Cell Therapy Quality with AI and ML
Xcell Biosciences has partnered with Culture Biosciences to integrate AI- and ML-driven analytics into cell therapy development. The collaboration leverages a cloud-based platform capable of multivariate analysis, enabling real-time optimisation to enhance cell therapy performance and improve patient outcomes.
Machine Learning | 10/12/2025 | By Akanki
Thermo Fisher Launches Molecular Microscope to Assess Lung Transplant Rejection
Thermo Fisher’s new Molecular Microscope Diagnostic System for Lung (MMDx Lung) leverages the power of Machine Learning (ML) to profile gene expression data from lung biopsies, comparing each new sample to a reference set of over 896 lung biopsies.
Machine Learning | 10/10/2025 | By Dineshwori
GlobalData's AI Tool Predicts Pharmaceutical Drug Approvals with 85 Percent Success Rate
GlobalData’s enhanced AI-powered Likelihood of Approval (LoA) model boosts its predictive power, providing probability of a drug receiving market authorisation.
Machine Learning | 29/09/2025 | By Dineshwori | 133
Lilly Plans to Build USD 6.5 Billion Facility to Manufacture APIs in Texas
Eli Lilly will invest USD 6.5 billion to set up a new API manufacturing facility in Houston, Texas—its eighth US site since 2020—creating over 4,600 jobs and boosting domestic production of small molecule medicines.
Machine Learning | 24/09/2025 | By Dineshwori | 225
Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform
Fischer Medical Ventures’ associate company, Nanyang Biologics (NYB), has entered into a strategic collaboration with global technology leaders NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build VECURA – an AI-powered drug discovery platform.
Machine Learning | 03/09/2025 | By Dineshwori | 223
LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform
LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.
Machine Learning | 23/05/2024 | By Aishwarya | 611
AI and ML devices transforming healthcare
AI and ML in medical devices transform healthcare aiding diagnosis accuracy: Koji Wada
Machine Learning | 19/04/2022 | By Sudeep Soparkar | 659
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy